Introduction
has been shown to display neuroprotective and anti-inflammatory properties in a number of neurologic diseases or their animal models, including traumatic brain injury, spinal cord injury, ischaemia, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
. Protective effects of minocycline in these disorders are considered due to inhibitory effects on immune cell activation, matrix metalloproteinase activity, nitric oxide production and cell apoptosis. Furthermore, minocycline has been shown to attenuate neuropathic pain in a variety of animal models through inhibiting spinal microglia activation [8, 9] .
Minocycline is commonly used as an antibiotic for the treatment of acne and its toxicity has been well tested [10] . The high lipophilicity of minocycline allows it to diffuse into the central and peripheral nervous system (CNS and PNS) at therapeutically effective levels [7] . Therefore, the proven reliability and safety of minocycline's use as an antibiotic suggest its potential prospect as an effective treatment of various neurologic conditions and in the present investigation, we analysed a possible protective effect of minocycline on rat EAN.
Materials and methods

Animal experiments
Male Lewis rats (8) (9) (10) [11] . For analysis of mechanical allodynia, EAN was induced by subcutaneous injection at the basal part of tails with reduced amount of P2 peptide (80 g) as described [6] , which was referred to as EAN pain (Fig. 3D-I ). 
ml PBS) was intraperitoneally injected once daily after immunization until the end of experiments, Day 17 or Day 30. As control, half of all EAN rats received intraperitoneal injection of the same volume of PBS (PBS control groups).
Tissue preparation
Mechanical allodynia
Mechanical allodynia was assessed by measuring rat hind-paw withdrawal threshold (HWT) using an automatic von Frey system, namely a mechanical plantar test apparatus (Ugo Basile, Milan, Italy
Statistical analysis
The unpaired t-tests were performed to compare differences between minocycline and PBS treated EAN rats for single time points and two-way ANOVA tests were performed to compare differences between both groups over time (Graph Pad Prism 4.0 software). For all statistical analyses, significance levels were set at P < 0.05.
Results
Effects of minocycline on pathological scores and body weight of EAN rats
EAN was induced by subcutaneous injection of P2 peptide for experimental suppressive treatment. Minocycline or PBS (PBS control group) were injected once daily, from Day 0 to Day 30 after immunization. PBS-treated rats developed the first neurological signs of EAN (reduced tonus of tail) 9 days after immunization
Effects of minocycline on circulating monocytes and lymphocytes in EAN rats
Effects of minocycline on expressions of MMP9 in EAN sciatic nerves
MMPs, particularly MMP-9, are known to facilitate the passage of leucocyte across matrix barriers and are important for the pathology of autoimmune disorders [17] . Previous studies have shown an increased expression of MMP-9 in inflamed peripheral nerves in EAN [18] . In our study, minocycline significantly attenuated MMP-9 protein accumulation in sciatic nerves of EAN rats ( Fig. 4A and B) .
It was also reported that maximal levels of MMP-9 mRNA in sciatic nerves of EAN rats was concurrent with maximal disease severity [18] . So we further analysed MMP-9 mRNA expression in EAN sciatic nerves following minocycline treatment. Total mRNA was isolated from sciatic nerves of 17-days EAN rats treated with minocycline or PBS. As shown in Fig. 4C and D, mRNA expression of MMP-9 in EAN sciatic nerves was significantly reduced in the minocycline treated. [19, 20] 
Effects of minocycline on expressions of inflammatory molecules in EAN sciatic nerves iNOS and inflammatory cytokines IL-1␤ and TNF-␣ are up-regulated in EAN and known to play important roles in inflammatory progression of disease
Effects of minocycline on mechanical allodynia and spinal glia activation in EAN rats
Minocycline is known to suppress neuropathic pain in a variety of animal models [8, 9] . Therefore, we studied the influence of minocycline on neuropathic pain, which was induced with a reduced amount of P2 peptide and base tail immunization to avoid severe motor deficit and hind-paw inflammation that impairs the assessment of mechanical allodynia [6] . Minocycline greatly suppressed mechanical allodynia in EAN (Fig. 6A) (Fig. 6A) . However, in minocycline-treated EAN rats, pain sensitivity shown by HWT remained comparable before and after immunization, indicating the absence of mechanical allodynia (Fig. 6A) . Therefore, minocycline could completely suppress the development of mechanical allodynia in EAN rats.
It is known that neuropathic pain can be due to central and/or peripheral sensitization [21] .
So we further studied the effects of minocycline on peripheral and central inflammation in EAN pain model. Similar to the standard EAN model described above, in sciatic nerves of EAN pain model, the infiltration of T cells, B cells and macrophages were greatly reduced following minocycline treatment and the accumulation of IL-1␤, TNF-␣, iNOS mRNA and MMP-9 protein were significantly reduced (data not shown). So in EAN pain model, minocycline greatly inhibited peripheral inflammation. We next examined the effects of minocycline on spinal glia activation, which has been recently recognized as an important factor for initiation and persistence of neuropathic pain. In the EAN pain model, spinal microglial activation was detected by ED-1 immunostaining at Day 17 EAN rats treated with minocycline or PBS. In PBS-treated EAN rats, emergence of ED1
ϩ cells were seen, mainly detected in grey matter, particularly in the superficial layers of dorsal horns (Fig. 6B) . But in the minocycline treated EAN rats, spinal ED1 ϩ cells were rarely seen (Fig. 6D) . Thus, a significant reduction [6] . As shown in Fig. 6C [7] . [24] . Therefore, minocycline could inhibit local immune cell infiltration to favour EAN outcome. [25] reported that minocycline inhibited human T-cell proliferation. Minocycline also suppressed the proliferation of murine thymocytes induced by IL-1 [26] . So minocycline might inhibit lymphocyte proliferation to reduce circulating lymphocytes. This observation was in line with previous reports about the direct suppressive effect of minocycline on activation of immune cells [7] and suggests that generally reduced activated immune cells in circulation could also contribute to the suppressed cellular accumulation in areas of inflammatory lesions. However, we observed that
of ED1 ϩ cells in lumbar dorsal horns of Day 17 EAN rats was detected after minocycline treatment (Fig. 6F). Spinal astrocyte activation in Day 17 EAN rats following minocycline was analysed as well. But no significant changes were seen (data not shown). P2X4R is an adenosine-5Ј-triphosphate (ATP)-gated ion channel and its spinal up-regulation has been found to be crucial to the development of neuropathic pain following peripheral nerve injury [22]. Our previous data have shown an increased P2X4R expression in spinal microglia that was negatively correlated with mean HWT values in EAN rats
Fig. 3 Minocycline suppressed macrophage, T cell and B-cell infiltration into sciatic nerves and suppressed circulating monocytes and lymphocytes in EAN rats. Seventeen days after immunization, sciatic nerves of both experimental groups were analysed by immunohistochemstry. ED-1 (A and D) immunostaining was used for macrophages, W3/13 (B and E) for T cells and OX22 (C and F) for B cells. Representative micrographs from minocycline treated and PBS control EAN rats are shown in (A-C) and (B-D), respectively. (G-I) Infiltration of macrophages, T cells and B cells into sciatic nerves was further semi-quantified as indicated in Experimental procedures and bar figures show quantified results. Minocycline treatment significantly reduced infiltration of macrophages, T cell and B cells into EAN sciatic nerves (mino: minocycline treatment). (J-K) Minocycline suppressed circulating monocytes and lymphocytes in EAN rats. Following the same treatment described above, blood was drawn intracardially and leucocyte populations analysed by FACS with monoclonal antibody ED-9 for monocytes (J), W3/13 for T cells (K) and OX33 for B cells (L). Bar figures show results of percentages of positive cells in blood. Minocycline significantly reduced the percentages of circulating monocytes and T cells. The unpaired t-test was performed to compare the differences (Graph Pad Prism 4.0 for windows). *P < 0.05 and ***P < 0.001 compared to their respective control.
Fig. 4 Minocycline suppressed accumulation of matrix metalloproteases-9 (MMP-9) in sciatic nerves of EAN rats. Seventeen days after immunization, sciatic nerves of both groups were taken and used for immunohistochemical staining of MMP-9 (A and B).
Representative immunohistochemical micrographs showed that minocycline significantly reduced the expression of MMP-9 in sciatic nerves. Another treatment group were used for analysis of mRNA level of MMP-9 (C and D). (C) Photos of gel electrophoresis with PCR products show obviously reduced mRNA levels of MMP-9 after treatment by minocycline. (D) Bar figures show semi-quantified results of imaging intensity relative to housekeeping gene GAPDH. The unpaired t-test was performed to compare the differences between minocycline treated and PBS control EAN rats (Graph Pad Prism 4.0 for Windows). **P < 0.01 compared to the PBS control. inflammatory molecule expression in sciatic nerves. Further, minocycline also significantly attenuated mechanical allodynia and inhibited microglia activation in spinal cords of EAN rats. As a member of the tetracycline class of antibiotics, minocycline has been shown to possess anti-inflammatory properties. In vitro and in vivo data have suggested that minocycline inhibited inflammation by modulating cellular activation and subsequent release of cytokines, chemokines, lipid mediators of inflammation, matrix metalloproteases (MMPs), and nitric oxide
In our EAN models, minocycline significantly suppressed infiltration of T cells, B cells and macrophages into peripheral nerves. Pathological development of EAN is characterized by the infiltration of reactive leucocyte into the PNS [23]. Activated autoreactive T cells, which can recognize peripheral nerve autoantigens on antigen presenting cells, are of importance for the initiation of EAN. Following activation, autoreactive T cells attach to the venular endothelium of the PNS, penetrate the BNB and generate an autoimmune reaction within the PNS that orchestrates the invasion of more lymphocytes and monocytes and local inflammation. Activated macrophages cause demyelination by direct phagocytic attack and secretion of inflammatory mediators. Depletion of macrophages and inhibition of their activity have been shown to suppress the development of EAN. Altogether, accumulation of reactive T cells and macrophages to the PNS are essential for EAN development
How minocycline reduces immune cell infiltration in sciatic nerves of EAN rats was not clear but might be due to its effects on reducing circulating immune cells and inhibiting MMP expression in sciatic nerves. In our study, circulating monocytes and T cells in the EAN rat were reduced by minocycline. Kloppenburg et al.
percentages of B cells in blood increased following minocycline treatment, which was not in line with the observation of reduced B cells infiltration in sciatic nerves. Following the application of minocycline, while percentages of circulating T cells and monocytes were greatly reduced compared to the PBS control, percentages of circulating B cells relatively increased, which could be owe to the strong decrease of circulating T cells and monocytes. While percentages of circulating B cells increased following minocycline treatment in EAN rats, the infiltration of B cells into sciatic nerves decreased. This might be because minocycline has also effects on immune cell infiltration. Under normal condition, it is impossible or rare for immune cells to pass the BNB to access peripheral nerves. However, in EAN, auto-active T cells and B cells and reactive monocytes can penetrate BNB to reach lesion site.
Minocycline is well known to inhibit MMP to decrease immune cell infiltration [7] . Therefore, following minocycline administration, infiltration of reactive immune cells to sciatic nerves was greatly reduced regardless of their percentages in blood.
MMPs are important for development of inflammation [27] , like enhancing effects of pro-inflammatory cytokines, regulating chemokine activity and activating defensins. In EAN, MMPs could participate in the disruption of the BNB, breakdown of the myelin sheath, the release of TNF-␣, and finally facilitate leucocyte invasion into the PNS [28] . In multiple sclerosis and its animal model EAE, MMPs are important for disease progression [29] . MMPs facilitate leucocyte infiltration into the CNS parenchyma by degrading the basement membrane that surrounds blood vessels, greatly impairing the integrity of the blood brain barrier (BBB) [29] . Further, serum MMP-9 levels closely correlated with disease activity demonstrated by gadolinium-enhanced MRI in MS patients [30] . In the nervous system, aberrant expression of MMPs may support disease activity by converting pro-forms of several inflammatory molecules, such as TNF-␣, into their active forms, resulting in the propagation of inflammation [31] . In addition, MMPs were reported to induce the degradation of myelin or axonal injury after injection into the brain [32] , and fragments of MMP-mediated digestion of myelin basic protein are encephalitogenic when injected into mice. Thereby, a cascade of demyelinating and pro-inflammatory events is generated in the nervous system as a result of aberrant MMP expression [33] .
Minocycline not only inhibits the enzymatic activity of MMPs, but also reduces the expression of several MMP family members [20] . TNF-␣ can greatly enhance BNB permeability, which contributes to EAN development [36] , and in particular to central and peripheral demyelination [20] . Therefore, the suppression of these inflammatory cytokines in EAN by minocycline can improve EAN outcome. Similar to inflammatory cytokines, iNOS is also important for the pathogenesis of EAN. iNOS functions to produce nitric oxide which possesses pro-inflammatory property including vasodilation, oedema, cytotoxicity and mediates cytokine-dependent processes that can result in tissue destruction [37] . In EAN, upregulation of iNOS was reported and was particularly related to pathogenesis of PNS cell-mediated demyelination and even axonal damage [38] . In our study, reduced expression of iNOS mRNA was also observed under administration of minocycline, which may inhibit activation of immune cells, and be an important part of minocycline's anti-inflammatory effect in EAN. Interestingly, inhibition of iNOS expression is considered to be a major mechanism of minocycline [7] . While accumulated data proposed several potential mechanisms of inhibitory activity of minocycline to microglia and macrophages, the exact mechanisms are not clear yet. One of the potential mechanism is that minocycline could inhibit the expression of iNOS, resulting in reduced release of NO and NOinduced phosphorylation of p38 MAPK (mitogen-activated protein kinase) [34] . Our observation in this study also supports this idea.
An interesting finding in this study is that minocycline attenuates mechanical allodynia in EAN rats. Neuropathic pain is a common symptom of human autoimmune polyneuropathy, occurring in 55-85% of cases [39] . In EAN, mechanical allodynia was successfully observed recently [5, 6] [41] . Activated microglia secretes pro-inflammatory cytokines, like IL-6, TNF-␣ and IL-1␤, which contribute to central sensitisation of neuropathic pain [42] .
In EAN spinal cords, glia activation is known and considered to be related to neuropathic pain [6, 43] 
